Candesartan Cilexetil.
- Published in:
- American Journal of Cardiovascular Drugs, 2010, v. 10, n. 5, p. 335, doi. 10.2165/11206300-000000000-00000
- By:
- Publication type:
- Article
Works matching IS 11753277 AND DT 2010 AND VI 10 AND IP 5
Results: 7
1
2
Riferminogene Pecaplasmide.
- Published in:
- American Journal of Cardiovascular Drugs, 2010, v. 10, n. 5, p. 343, doi. 10.2165/11533480-000000000-00000
- Publication type:
- Article
3
Cardiovascular Risk-Benefit Profile of Sibutramine.
- Published in:
- American Journal of Cardiovascular Drugs, 2010, v. 10, n. 5, p. 321, doi. 10.2165/11584800-000000000-00000
- By:
- Publication type:
- Article
4
The Role of Angiotensin Receptor Blocker and Calcium Channel Blocker Combination Therapy in Treating Hypertension.
- Published in:
- American Journal of Cardiovascular Drugs, 2010, v. 10, n. 5, p. 315, doi. 10.2165/11538850-000000000-00000
- By:
- Publication type:
- Article
5
A 50-Week Extension Study on the Safety and Efficacy of Colesevelam in Adults with Primary Hypercholesterolemia.
- Published in:
- American Journal of Cardiovascular Drugs, 2010, v. 10, n. 5, p. 305, doi. 10.2165/11584310-000000000-00000
- By:
- Publication type:
- Article
6
The Impact of Upper Gastrointestinal Symptoms on Nonadherence to, and Discontinuation of, Low-Dose Acetylsalicylic Acid in Patients with Cardiovascular Risk.
- Published in:
- American Journal of Cardiovascular Drugs, 2010, v. 10, n. 5, p. 281, doi. 10.2165/11584410-000000000-00000
- By:
- Publication type:
- Article
7
An Olmesartan Medoxomil-Based Treatment Algorithm is Effective in Achieving 24-Hour BP Control in Patients with Type 2 Diabetes Mellitus, Regardless of Age, Race, Sex, or Severity of Hypertension.
- Published in:
- American Journal of Cardiovascular Drugs, 2010, v. 10, n. 5, p. 289, doi. 10.2165/11584690-000000000-00000
- By:
- Publication type:
- Article